drugset / Trial / NCT02755545

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

NCT02755545

Phase 4 Completed 127 enrolled Galderma R&D
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.

Timeline

Start
2016-05-01
Primary completion
2017-04-04
Completion
2017-04-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified Topical
Comparator salicylic acid Small molecule Topical

Indications